NCT00243165Unknown2 期
Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 60
- 主要终点
- Prevention of myelotoxicity-every week during chemotherapy.
研究概览
简要总结
This study will include 60 patients with early breast cancer referred to receive adjuvant chemotherapy with AC ( adriamycin- cyclophosphamide) or CAF ( adriamycin- cyclophosphamide- 5- fluorouracil ) combinations. These patients will receive every day one spoon of Lifemel honey or regular honey ( double blind)- during the adjuvant chemotherapy .Every week a WBC count will be performed in order to record the influence of Lifemel on myelotoxicity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •breast cancer patient treated with adjuvant chemotherapy
- •PS = 2 or less
排除标准
- 未提供
结局指标
主要结局
Prevention of myelotoxicity-every week during chemotherapy.
次要结局
未报告次要终点
研究者
相似试验
Unknown
不适用
Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast CancerEarly-stage Breast CancerNCT03797248Chang Gung Memorial Hospital310
Unknown
2 期
Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast CancerEarly Stage Breast CarcinomaNCT02095743Centre Henri Becquerel256
终止
1 期
Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast CancerStages II-III Breast CancerNCT01090128University of Utah27
已完成
不适用
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal SymptomsArthralgiaBreast CancerNCT02118636Lynn Henry75
已完成
不适用
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic ImagingBreast CancerNCT02510456Boston Medical Center24